PHG Stock Recent News

Koninklijke Philips N.V. (NYSE:PHG ) Q1 2025 Earnings Conference Call May 6, 2025 4:00 AM ET Company Participants Durga Doraisamy - Head-Investor Relations Roy Jakobs - President & Chief Executive Officer Charlotte Hanneman - Executive Vice President & Chief Financial Officer Conference Call Participants Richard Felton - Goldman Sachs David Adlington - JPMorgan Veronika Dubajova - Citi Hassan Al-Wakeel - Barclays Graham Doyle - UBS Lisa Clive - Bernstein Julien Dormois - Jefferies Robert Davies - Morgan Stanley Hugo Solvet - BNP Paribas Exane Wim Gille - ABN ODDO Julien Ouaddour - Bank of America Sezgi Oezener - HSBC Falko Friedrichs - Deutsche Bank Operator Welcome to The Royal Philips' First Quarter 2025 Results Conference Call on Tuesday, May 6, 2025.

Shares of medical equipment company Koninklijke Philips (PHG) shares are dropping Tuesday after the Dutch conglomerate said it had cut its target profit margin due to tariffs.

Roy Jakobs, CEO of Philips, discusses the efforts the Dutch health technology firm is taking to mitigate the tariff impact from the United States, from localizing supply chains to "decisive cost actions."

The health-technology group lowered its full-year earnings margin target as it aims to navigate the financial impact from U.S. tariffs through an improved supply-chain network and cost discipline.

May 6, 2025 Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasing Comparable order intake increased 2% despite China decline Income from operations increased to EUR 154 million Adjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasing Free cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in US Updated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs, CEO of Royal Philips: “We remain dedicated to serving our customers, driving profitable growth and delivering better care for more people. Our order intake growth continued with strong momentum particularly in the US, coupled with positive growth in personal health, providing an encouraging s

The World's Most intelligent Shaver from Philips Norelco sets new standards for closeness, comfort and customization. CAMBRIDGE, Mass.

April 25, 2025 Amsterdam, the Netherlands –  Royal Philips (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM agenda includes the proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025, given his extensive expertise and experience in health technology and quality.

March 25, 2025 Amsterdam, the Netherlands –  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that in 2024 it was the leading applicant in the field of medical technology at the European Patent Office (EPO), filing 594 Medtech patent applications. This achievement underscores the company's ongoing dedication to transforming healthcare delivery by integrating informatics and AI to improve workflows, enhance the quality of care, and lower costs of care per patient.

March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pathologists and the growing number of cancer patients. Following the start of the partnership in 2021, Philips and Ibex can now offer even further interoperability of its solutions, aiming to enhance diagnostic workflows for clinicians and enabling better care for more people.

March 24, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes. As previously announced, the agenda includes: